• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    Closed System Drug Transfer Device Market Research Report - Forecast till 2032 Infographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Closed System Drug Transfer Device Market

    ID: MRFR/Pharma/6264-CR
    146 Pages
    Rahul Gotadki
    March 2024

    Closed System Drug Transfer Device Market Research Report Information By type (Membrane to Membrane and Needleless System), By Component (Vial Access Devices, Syringe Safety Devices, Accessories, Bag/Line Access Devices), By Closing Mechanism (Push to Turn System, Color-to-color Alignment System, Leur Lock Systems, Click to Lock Systems), By Technology (Compartmentalize Devices, Diaphragm-Based Devices, and Air Filtration Devices) By End-Users (Hospitals & Clinics, Specialty Centers, and Others) And By Region (North America, Europe, Asia...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Closed System Drug Transfer Device Market Research Report - Forecast till 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    Closed System Drug Transfer Device Market Summary

    As per Market Research Future Analysis, the Global Closed System Drug Transfer Device Market was valued at USD 1.07 billion in 2023 and is projected to reach USD 2.87 billion by 2032, growing at a CAGR of 10.17% from 2024 to 2032. The market growth is driven by the rising incidences of cancer globally and stringent healthcare regulations. The increasing focus on occupational safety and technological advancements in CSTD design further support market expansion.

    Key Market Trends & Highlights

    Key trends driving the market include the following:

    • The membrane-to-membrane systems segment dominated the market in 2023, while needleless systems are expected to be the fastest-growing segment during 2024-2032.
    • Syringe safety devices led the component segment in 2023, with accessories projected to grow the fastest in the same period.
    • North America held the largest market share of 38.14% in 2023, anticipated to reach USD 9.92 billion by 2032.
    • The specialty centers segment is expected to be the fastest-growing end-user segment during the forecast period.

    Market Size & Forecast

    2023 Market Size USD 1.07 Billion
    2024 Market Size USD 1.20 Billion
    2032 Market Size USD 2.87 Billion
    CAGR (2024-2032) 10.17%

    Major Players

    B. Braun SE, JMS Co., Ltd., ICU Medical, Inc., Simplivia, Equashield, Becton, Dickinson and Company, Baxter International Inc.

    Closed System Drug Transfer Device Market Trends

    Increasing incidences of cancer across the globe

    The increasing incidences of cancer across the globe are significantly driving the global closed-system drug transfer device (CSTD) market. This is because cancer treatment often requires hazardous drugs that can be harmful to healthcare workers handling them. The system provides a closed and leak-proof system that helps the escape of these hazardous drugs into the environment. Further, the cancer burden is rising across the globe due to factors such as an aging population, environmental factors, better diagnostic capabilities, and lifestyle changes that are fostering market growth.

    For instance, according to the International Agency for Research on Cancer, there were cancer cases of nearly 9,826,539 in Asia, 4,471,422 in Europe, 2,673 174 in Northern America, 1,551,060 in Latin America and the Caribbean, 1,185,216 in Africa, and 269 088 in Oceania in 2022. As per the International Agency for Research on Cancer, there were 192,020 breast cancer cases, 143,759 lips, oral cavity, 127,526 cervix uteri, 81,748 lung, 70,637 esophagus, 70,038 colorectum, and 727,588 cancer cases of others.

    The growing focus on occupational safety, coupled with technological advancements in CSTD functionality and design, is accelerating its adoption across healthcare facilities worldwide. Also, healthcare providers prioritize both provider's and patients’ health; the demand for CSTDs is expected to continue in response to the escalating cancer burden worldwide.

    Closed System Drug Transfer Device Market

    The increasing emphasis on safety and efficacy in drug handling practices appears to drive the adoption of closed system drug transfer devices across healthcare settings.

    U.S. Food and Drug Administration (FDA)

    Closed System Drug Transfer Device Market Drivers

    Market Growth Projections

    The Global Closed System Drug Transfer Device Market Industry is projected to experience substantial growth over the coming years. The market is expected to reach 1.2 USD Billion in 2024 and is forecasted to grow to 3.84 USD Billion by 2035, indicating a robust CAGR of 11.15% from 2025 to 2035. This growth trajectory reflects the increasing demand for safe drug transfer solutions in healthcare settings, driven by factors such as regulatory compliance, technological advancements, and rising awareness of occupational hazards. The market dynamics suggest a promising future for closed system drug transfer devices.

    Expansion of Healthcare Infrastructure

    The Global Closed System Drug Transfer Device Market Industry is poised for growth as healthcare infrastructure expands globally. Emerging economies are investing in healthcare facilities to improve patient care and safety standards. This expansion includes the establishment of oncology centers and specialized clinics that require safe drug handling solutions. As these facilities become operational, the demand for closed system drug transfer devices is expected to rise significantly. The focus on enhancing healthcare infrastructure aligns with the global trend towards safer drug administration practices, further propelling the market for closed system drug transfer devices.

    Increasing Adoption of Safety Standards

    The Global Closed System Drug Transfer Device Market Industry is witnessing a surge in the adoption of stringent safety standards aimed at minimizing exposure to hazardous drugs. Regulatory bodies are emphasizing the need for closed systems to protect healthcare workers and patients alike. For instance, the implementation of guidelines by the Occupational Safety and Health Administration (OSHA) has prompted healthcare facilities to invest in closed system devices. This trend is expected to drive the market, as organizations seek compliance with safety regulations, thereby enhancing the demand for closed system drug transfer devices.

    Growing Awareness of Occupational Hazards

    The Global Closed System Drug Transfer Device Market Industry is experiencing growth due to heightened awareness of occupational hazards associated with hazardous drug handling. Healthcare professionals are increasingly recognizing the risks posed by exposure to cytotoxic drugs, leading to a demand for safer handling practices. Educational initiatives and training programs are being implemented to inform healthcare workers about the dangers and the importance of using closed system devices. This awareness is fostering a cultural shift towards prioritizing safety in healthcare settings, thereby driving the adoption of closed system drug transfer devices across various healthcare facilities.

    Rising Incidence of Cancer and Chronic Diseases

    The Global Closed System Drug Transfer Device Market Industry is significantly influenced by the increasing prevalence of cancer and chronic diseases. As the number of patients requiring chemotherapy and other hazardous drug therapies rises, the demand for safe drug handling solutions escalates. According to projections, the market is anticipated to grow from 1.2 USD Billion in 2024 to 3.84 USD Billion by 2035, reflecting a compound annual growth rate (CAGR) of 11.15% from 2025 to 2035. This growth is largely driven by the need for effective and safe drug administration methods, highlighting the critical role of closed system drug transfer devices.

    Technological Advancements in Drug Delivery Systems

    The Global Closed System Drug Transfer Device Market Industry is benefiting from rapid technological advancements in drug delivery systems. Innovations such as improved materials and design features enhance the safety and efficacy of drug transfer processes. For example, the introduction of devices with integrated safety features reduces the risk of contamination and exposure to hazardous substances. These advancements not only improve user experience but also align with the evolving needs of healthcare providers. As technology continues to evolve, the market for closed system drug transfer devices is likely to expand, driven by the demand for more sophisticated and reliable solutions.

    Market Segment Insights

    Global Closed System Drug Transfer Device Type Insight

    Based on type, the global closed-system drug transfer device market has been segmented into membrane-to-membrane systems and needless systems. The membrane-to-membrane systems segment dominated the market in 2023, and needless systems is projected to be the fastest-growing segment during the forecast period, 2024–2032.

    In 2023, the Membrane-to-Membrane Systems segment dominated the global closed-system transfer device market. The membrane-to-membrane drug transfer devices use a dual membrane system between the syringe and vial to isolate the medical product. Factors such as reduced contamination risk and ease of use of double-membrane systems indicate the safety of membrane-to-membrane drug transfer devices, which is expected to boost their adoption in the coming years.

    Furthermore, the rising awareness of CSTD devices for the treatment of chronic diseases and growing adoption of membrane-to-membrane safety devices owing to prevention from exposure to harmful substances by creating a barrier between hazardous drugs and healthcare professional are driving Membrane-to-Membrane Systems segment.

    The needless system is expected to be the fastest growing segment throughout the forecast period owing to advantages such as needle free drug delivery. Additionally, new product launches and adoption of eco-friendly designs which minimize the single use plastics and other disposable material are projected to add to the rapid expansion of accute care needleless systems.

    FIGURE 2: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET SIZE, BY TYPE, 2023 & 2032 (USD BILLION)

    CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET SIZE, BY TYPE, 2023 & 2032

    Source: Secondary Research, Primary Research, Market Research Future Database, and Analyst Review

    Global Closed System Drug Transfer Device Component Insight

    Based on component, the Closed System Drug Transfer Device Market has been segmented into vial access devices, syringe safety devices, bag/line access devices, and accessories. The syringe safety devices segment dominated the market in 2023, and accessories is projected to be the fastest-growing segment during the forecast period, 2024–2032.

    The bag/line access devices segment includes products such as connectors, tubing sets, plugs, and many others utilized for drug delivery safety. Increasing demand for bag/line access devices for cancer, respiratory illnesses, and other ailments will drive market expansion throughout the forecast period.

    Vial access components are essential for maintaining the integrity of drug transfer procedures in closed systems, which reduces the possibility of contamination and hazardous material exposure for patients and healthcare personnel. Due to strict regulations and increased awareness of the significance of safe drug administration, the increasing use of CSTDs in a variety of healthcare settings is expected to drive demand for vial access components, which will support their high CAGR in the closed system transfer devices market.

    Additionally, there are several types of vial access devices available, including needle-free models that automatically balance vial pressure by lowering aerosols, stopping medication vaporization and leakage, and releasing the required amount of medication from the device.

    Moreover, the closed syringe safety devices facilitate the transfer of fluid using a syringe and various components through dedicated device connections. These devices prevent the wastage of drugs which provides an easy method to deliver hazardous drugs and reduce confusion. Companies such as B. Braun Medical Inc. offer OnGuard syringe adaptor, a closed system drug transfer device for easy delivery of drug to the patient.

    Global Closed System Drug Transfer Device Closing Mechanism Insight

    Based on closing mechanism, the Closed System Drug Transfer Device Market has been segmented into push to turn system, color-to-color alignment system, leur lock systems, and click-to lock system.

    Color-to-color alignment systems allow for the exact and efficient movement of materials in closed settings, ensuring safety and precision in industries such as pharmaceuticals, biotechnology, and chemical manufacturing. With a growing emphasis on contamination control and severe regulatory requirements, demand for closed-system transfer devices with color-to-color alignment systems is likely to rise. As companies prioritize safety and efficiency in their operations, color-to-color alignment systems within closed-system transfer devices are expected to see significant expansion in the near future.

    It is easier for healthcare professionals to use a push-to-turn connection mechanism system with a one-step straight-push mechanism. Patient safety is just as vital as health care professional safety. The number of firms producing airtight and leak-proof connections for transporting and administering drugs within a closed system is growing. Corvida Medical, headquartered in the greater Iowa City area, develops technology that is intended to represent better solutions for the safe handling of hazardous pharmaceuticals as well as quality in design. The company manufactures Halo, a smarter closed-system transfer device solution for chemotherapy and hazardous drugs.

    Moreover, a Luer lock syringe enables a needle to be twisted onto the tip and locked into place, providing a secure connection, and preventing accidental removal of the needle and injection of contents. Luer lock fittings are securely joined by means of a tabbed hub on the female fitting which screws into threads in a sleeve on the male fitting. It allows a needle to be twisted onto the tip and then locked in place. An increasing number of manufacturers are producing new and refined drug-delivery products.

    For instance, Simplivia Healthcare Ltd. (Israel) manufactures Tevadaptor luer lock adaptor which converts any standard female luer lock port (e.g., patient access port) to a safe and closed Tevadaptor connection. The other CSTD closing mechanism includes click to lock systems. Increasing number of cancer incidence globally and the need of such devices to reduce the risk associated while handling hazardous drugs is propelling the market growth for this segment.

    In addition to that, push-to-turn systems will witness the fastest growing market in the forecast period as these systems are increasingly being used for the safe transmission of hazardous medical substances. The large revenue share of closed-system transfer devices is mostly due to increased research and development activities in closed-system transfer devices for oncology medication transfer.

    Furthermore, click to lock systems features a precise locking mechanism that ensures a tight and sealed connection between the device and drug vials or IV bags. This mechanism typically involves a straightforward click-to-lock action, which effectively seals off any potential leakage points and prevents the escape of hazardous substances. The design prioritizes user-friendliness and safety, allowing healthcare professionals to confidently handle medications without the risk of exposure to harmful vapors or particles. Additionally, CSTDs often incorporate supplementary features such as integrated filters or secondary seals to further enhance containment capabilities and ensure compliance with rigorous safety standards.

    Global Closed System Drug Transfer Device Closing Technology Insight

    Based on technology, the Closed System Drug Transfer Device Market has been segmented into compartmentalize devices, diaphragm-based devices, and air filtration devices. The diaphragm-based devices segment dominated the market in 2023, and air filtration devices are projected to be the fastest-growing segment during the forecast period, 2023–2032.

    The expansion of the compartmentalized device category is mostly due to the devices' simplicity of operation and safety. Furthermore, Diaphragm-based devices are expected to grow at the highest CAGR in the closed system transfer devices market. This growth projection is primarily related to their exceptional performance in assuring the safe and efficient transfer of hazardous substances, drugs, and fluids, hence limiting the danger of contamination and exposure among healthcare professionals and patients. Diaphragm-based systems are becoming more popular for a variety of applications in healthcare settings due to their increased dependability, precision, and usability.

    With a growing emphasis on patient safety, together with technological developments and increased awareness of the relevance of CSTDs, demand for diaphragm-based solutions is predicted to skyrocket, accelerating their market growth at a rapid pace.

    In addition, closed system medication transfer systems prohibit pollutants from entering the system via a physical barrier or air filtering technology. The CSTD air-cleaning technology is based on an activated carbon filter and a membrane that allows the medicine to be kept sterile by filtration of air entering the vial during pressure equalization.

    Global Closed System Drug Transfer Device Closing End User Insight

    Based on end user, the Closed System Drug Transfer Device Market has been segmented into hospitals & clinics, specialty centers, and others. The hospitals & clinics segment dominated the market in 2023, and specialty centers is projected to be the fastest-growing segment during the forecast period, 2024–2032.

    The hospitals and clinics segment accounted for the largest market share. The high adoption of CSTD systems in hospitals & clinics is due to the high purchasing power of big hospitals and the growing healthcare infrastructure. While hospitals and clinics are the primary facilities where patients who need a variety of medical treatments and procedures seek treatment, there is a greater need for safety precautions such as closed system transfer devices to avoid drug exposure and contamination.

    In addition, hospitals and clinics have to invest in cutting-edge technology like CSTDs to ensure patient safety and compliance with the strict regulatory standards that are imposed in healthcare facilities. These regulations require the adoption of safe handling methods. As a result, hospitals and clinics' combined demand plays a major role in their significant share in the closed system drug transfer device market.

    The specialty centers segment is expected to be the fastest-growing end user segment. This is attributed to the growing awareness and adoption of CSTD devices for the delivery of many diseases as well as the increasing number of patients suffering from chronic diseases. Furthermore, others include academic and healthcare institutions and research laboratories. Moreover, factors such as advancements in academic research and the rising demand from healthcare institutions for safer and more effective drug delivery methods will drive the market growth during the forecast period.

    Regional Insights

    Based on region, the Closed System Drug Transfer Device Market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest market share in 2023 and is anticipated to reach USD 9.92 billion by 2032, registering a CAGR of 9.10% during the forecast period.

    North America accounted for the largest market share of 38.14% and is estimated to dominate the global CSTD market. This large market share is due to the increasing prevalence of cancer cases and the strong research and development infrastructure. For instance, In the United States in 2020, there were 1,603,844 new cancer cases reported and 602,347 cancer deaths. There were 403 new cancer cases reported for every 100,000 people, and 144 people died from cancer. Moreover, Technological advancements in CSTDs are further driving market growth.

    Modern devices incorporate innovative features such as air filtration systems, leak-proof connectors, and enhanced compatibility with various drug delivery systems, thereby improving their effectiveness and usability in clinical settings

    The Americas region is followed by Europe, which accounted for the second largest closed system drug transfer device market share. One of the primary drivers is the increasing prevalence of chronic diseases across the region, which necessitates efficient and safe drug delivery mechanisms. This demographic trend is fueling demand for advanced drug transfer devices that offer enhanced safety and precision in medication administration. Additionally, stringent regulations and guidelines pertaining to healthcare worker safety are pushing healthcare facilities to adopt closed-system drug transfer devices (CSTDs) to minimize occupational exposure to hazardous drugs.

    Moreover, technological advancements in drug transfer devices, such as the integration of smart features and materials that ensure compatibility with a wide range of medications, are further propelling market expansion. These factors collectively contribute to a favorable landscape for growth in the Europe drug transfer devices market, promising continued innovation and adoption in the years ahead.

    Asia-Pacific is expected to witness significant growth and is projected to be the fastest growing region over the forecast period due to the increasing number of new vendors involved in the drug-device system, as many regional/small market players are trying to leverage the market share. In 2019, there were only 62 dedicated cancer care hospitals in India, including both regional and national facilities, according to the National Institute of Health. The estimated number of cancer incidents in India for the year 2022 was 14,61,427 (crude rate: 100.4 per 100,000).

    In India, one in every nine people will develop cancer during their lifetime. Lung and breast cancers were the most common cancer sites in men and women, respectively. Thus, the increasing cancer patient pool will propel the demand for closed drug delivery systems which will boost the market growth in the region. Additionally, the availability of skilled workforce and low production cost in the region portrays an opportunity for global players to enter untapped markets in Asia-Pacific.

    FIGURE 3: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET BY REGION 2023 & 2032 (USD BILLION)

    CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET BY REGION 2023 & 2032

    Key Players and Competitive Insights

    The Closed System Drug Transfer Device Market is characterized by the presence of many global, regional, and local vendors. The market is highly competitive, with all the players competing to gain maximum market share. Intense competition, frequent changes in government policies, and regulations are key factors that impact market growth. The vendors compete based on cost, product quality, reliability, and aftermarket services.

    Product launch and approvals were also observed to expand the company's product portfolio. The growth of prominent industry players is dependent on various factors, such as market conditions, product differentiation and innovation, and pricing strategies. It is also projected that increasing investment in healthcare infrastructure and rising awareness and education associated with the closed system drug transfer device (CSTDs) benefits will also boost the market's growth in the upcoming future. 

    Major players in the Closed System Drug Transfer Device Market, including Becton, Dickson, and Company, Inc, Baxter International Inc., ICU Medical, Inc., JMS Co.Ltd, B. Braun SE, Equashield, and others are making investments in R&D activities to boost market demand.

    Braun is a healthcare supplier and manufacturer that offers its products to hospitals, surgical units, private practices (medical care and doctors' offices), and extracorporeal blood treatments. The company operates through three major business segments: Hospital Care, Aesculap, and Avitum. Furthermore, B. Braun offers a wide range of medical devices and systems for hospitals and healthcare facilities. They invest significantly in research and development (R&D) to introduce new products, improve existing ones, and address unmet medical needs.

    Moreover, In December 2021, B. Braun Medical Inc. has introduced the next generation OnGuard 2 CSTD in the United States. Building on the strengths of its predecessor, OnGuard 2 incorporates upgraded materials and enhanced features aimed at improving usability while retaining all the existing advantages of the original OnGuard device.

    Key Companies in the Closed System Drug Transfer Device Market market include

    Industry Developments

    December 2023: Equashield announced the launch of its latest product, the Mundus Mini HD. Leveraging Equashield’s CSTDs, the Mundus Mini HD aims to minimize contamination, exposure, and errors, thereby enhancing compounding safety and efficiency.

    October 2023: The EQUASHIELD Syringe Unit has received additional FDA clearance for full volume use.

    April 2022: Simplivia has launched Chemfort, its latest closed system transfer device (CSTD). Chemfort is designed to significantly minimize the risk of exposure for healthcare professionals during the preparation and administration of hazardous drugs.

    December 2021: B. Braun SE introduced the next generation OnGuard 2 CSTD in the US. Building on the strengths of its predecessor, OnGuard 2 incorporates upgraded materials and enhanced features aimed at improving usability while retaining all the existing advantages of the original OnGuard device.

    Future Outlook

    Closed System Drug Transfer Device Market Future Outlook

    The Closed System Drug Transfer Device Market is projected to grow at 11.15% CAGR from 2024 to 2035, driven by increasing safety regulations and rising demand for oncology drugs.

    New opportunities lie in:

    • Develop innovative devices integrating smart technology for enhanced safety monitoring.
    • Expand product lines to cater to emerging markets with tailored solutions.
    • Invest in partnerships with healthcare providers for comprehensive training and support services.

    By 2035, the market is expected to achieve substantial growth, reflecting heightened safety standards and technological advancements.

    Market Segmentation

    Outlook

    • US
    • Canada
    • Mexico
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
    • Middle East & Africa
    • South America

    Type Outlook

    • Membrane-To-Membrane Systems
    • Needleless Systems

    Global Closed System Drug Transfer Regional Outlook

    • US
    • Canada
    • Mexico
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
    • Middle East & Africa
    • South America

    Global Closed System Drug Transfer Component Outlook

    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Global Closed System Drug Transfer End Users Outlook

    • Hospitals & clinics
    • Specialty centers
    • Others

    Global Closed System Drug Transfer Technology Outlook

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices

    Global Closed System Drug Transfer Device Type Outlook

    • Membrane-To-Membrane Systems
    • Needleless Systems

    Global Closed System Drug Transfer Closing Mechanism Outlook

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 USD 1.07 billion
    Market Size 2024 USD 1.20 billion
    Market Size 2032 USD 2.87 billion
    Compound Annual Growth Rate (CAGR) 10.17% (2024-2032)
    Base Year 2023
    Forecast Period 2024-2032
    Historical Data 2019 to 2022
    Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends.
    Segments Covered Type, Component, Closing Mechanism, Technology, End Users, and Region.
    Key Companies Profiled B. Braun SE (Germany), JMS Co., Ltd. (Japan), ICU Medical, Inc. (US), Simplivia (Israel), Equashield (US), Becton, Dickinson and Company (US), Baxter International Inc. (US), Cormed (US), Yukon Medical (US), Caragen Ltd. (Ireland).
    Key Market Opportunities ·       Growing technological advancements in closed system drug transfer devices (CSTDs)
    Key Market Dynamics ·       Increasing incidences of cancer across the globe. ·       Stringent regulatory requirements within the healthcare industry.

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    How much is the Closed System Drug Transfer Device Market?

    The Closed System Drug Transfer Device Market is anticipated to reach 2.87 billion at a CAGR of 10.17% during the forecast period of 2024-2032.

    What is the growth rate of the Closed System Drug Transfer Device Market?

    The Closed System Drug Transfer Device Market is expected to grow at a 10.17% CAGR during the forecast period from 2024 to 2032.

    Which region held the largest market share in 2023 in the Closed System Drug Transfer Device Market?

    The North America region market is estimated to hold the largest market share in the Closed System Drug Transfer Device Market.

    Who are the key players in the Closed System Drug Transfer Device Market?

    The key players include B. Braun SE (Germany), JMS Co., Ltd. (Japan), ICU Medical, Inc. (US), Simplivia (Israel), Equashield (US), Becton, Dickinson and Company (US), Baxter International Inc. (US), Cormed (US), Yukon Medical (US), Caragen Ltd. (Ireland).

    Which Technology segment led the Closed System Drug Transfer Device Market in 2023?

    Diaphragm-based devices segment dominated the market in 2023.

    1. EXECUTIVE SUMMARY
    2. MARKET INTRODUCTION
    3. DEFINITION
      1. SCOPE OF THE STUDY
      2. RESEARCH OBJECTIVE
      3. MARKET
    4. STRUCTURE
    5. RESEARCH METHODOLOGY
      1. OVERVIEW
      2. DATA FLOW
    6. Data Mining Process
      1. PURCHASED DATABASE:
      2. SECONDARY SOURCES:
        1. Secondary Research data flow:
      3. PRIMARY RESEARCH:
        1. Primary
    7. Research DATA FLOW:
      1. APPROACHES FOR MARKET SIZE ESTIMATION:
        1. Revenue
    8. Analysis Approach
      1. DATA FORECASTING
        1. Data forecasting Type
      2. DATA MODELING
        1. microeconomic factor analysis:
        2. Data modeling:
      3. TEAMS AND ANALYST CONTRIBUTION
    9. MARKET DYNAMICS
      1. INTRODUCTION
      2. DRIVERS
        1. Increasing incidences of cancer across the globe
    10. stringent regulatory requirements within the healthcare industry
      1. RESTRAINTS
        1. HIGH COST ASSOCIATED WITH CSTD
      2. OPPORTUNITY
        1. Growing Technological
    11. advancements in Closed System Drug Transfer Devices (CSTDs)
    12. MARKET FACTOR ANALYSIS
      1. PORTER’S FIVE FORCES MODEL
        1. Threat of New Entrants
        2. BARGAINING POWER OF SUPPLIERS
        3. Threat of Substitutes
    13. Bargaining Power of Buyers
      1. Intensity of Rivalry
      2. IMPACT OF COVID-19
    14. ON THE GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET
    15. GLOBAL CLOSED
    16. SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE
      1. INTRODUCTION
      2. MEMBRANE-TO-MEMBRANE
    17. SYSTEMS
      1. NEEDLELESS SYSTEM
    18. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE
    19. MARKET, BY COMPONENT
      1. INTRODUCTION
      2. SYRINGE SAFETY DEVICE
    20. VIAL ACCESS DEVICES
      1. ACCESSORIES
      2. BAG/LINE ACCESS DEVICES
    21. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM
    22. INTRODUCTION
      1. PUSH TO TURN SYSTEM
      2. COLOR-TO-COLOR ALIGNMENT SYSTEM
      3. LEUR LOCK SYSTEMS
      4. CLICK-TO-LOCK
    23. GLOBAL CLOSED SYSTEM DRUG
    24. TRANSFER DEVICE MARKET, BY TECHNOLOGY
      1. INTRODUCTION
      2. COMPARTMENTALIZE
    25. DEVICES
      1. DIAPHRAGM-BASED DEVICES
      2. AIR FILTRATION DEVICES
    26. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY END USER
      1. INTRODUCTION
      2. HOSPITALS & CLINICS
      3. SPECIALTY CENTERS
      4. OTHERS
    27. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY REGION
      1. OVERVIEW
      2. NORTH AMERICA
        1. US
        2. Canada
        3. Mexico
      3. EUROPE
        1. Germany
        2. France
        3. UK
        4. Italy
        5. Spain
        6. Rest of Europe
      4. ASIA-PACIFIC
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Australia
        6. Rest of Asia-pacific
      5. REST OF THE WORLD
        1. Middle East
        2. Africa
        3. Latin
    28. America
    29. COMPETITIVE LANDSCAPE
      1. INTRODUCTION
      2. MARKET SHARE
    30. ANALYSIS, 2023
      1. COMPETITOR DASHBOARD
      2. PUBLIC PLAYERS STOCK SUMMARY
      3. COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
      4. KEY DEVELOPMENTS &
    31. GROWTH STRATEGIES
      1. product launch
        1. product Approval
    32. COMPANY PROFILES
      1. B. BRAUN SE
        1. COMPANY OVERVIEW
    33. FINANCIAL OVERVIEW
      1. PRODUCTS OFFERED
        1. KEY DEVELOPMENTS
        2. SWOT ANALYSIS
        3. KEY STRATEGIES
      2. JMS CO.LTD.
    34. COMPANY OVERVIEW
      1. FINANCIAL OVERVIEW
        1. PRODUCTS OFFERED
        2. KEY DEVELOPMENTS
        3. KEY STRATEGIES
      2. ICU MEDICAL, INC.
        1. COMPANY OVERVIEw
        2. FINANCIAL OVERVIEW
        3. Product OFFERed
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS
        6. KEY STRATEGIES
      3. SIMPLIVIA
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. KEY STRATEGIES
      4. EQUASHIELD
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. KEY STRATEGIES
      5. BD
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
    35. productS OFFERED
      1. KEY DEVELOPMENTS
        1. SWOT ANALYSIS
    36. KEY STRATEGIES
      1. BAXTER
        1. COMPANY OVERVIEW
        2. FINANCIAL
    37. OVERVIEW
      1. productS OFFERED
        1. KEY DEVELOPMENTS
        2. SWOT
    38. ANALYSIS
      1. KEY STRATEGIES
      2. CORMED
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. productS OFFERED
        4. KEY DEVELOPMENTS
        5. KEY STRATEGIES
      3. YUKON MEDICAL
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS
        6. KEY STRATEGIES
      4. CARAGEN LTD
    39. COMPANY OVERVIEW
      1. FINANCIAL OVERVIEW
        1. products OFFERED
        2. KEY DEVELOPMENTS
        3. KEY STRATEGIES
    40. DATA CITATIONS
    41. ASSESSMENT
    42. –2032 (USD MILLION)
    43. MARKET, FOR MEMBRANE-TO-MEMBRANE SYSTEMS, BY REGION, 2019–2032 (USD MILLION)
    44. BY REGION, 2019–2032 (USD MILLION)
    45. TRANSFER DEVICE MARKET, BY COMPONENT, 2019–2032 (USD MILLION)
    46. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR SYRINGE SAFETY DEVICE, BY
    47. REGION, 2019–2032 (USD MILLION)
    48. DEVICE MARKET, FOR VIAL ACCESS DEVICES, BY REGION, 2019–2032 (USD MILLION)
    49. REGION, 2019–2032 (USD MILLION)
    50. DEVICE MARKET, FOR BAG/LINE ACCESS DEVICES, BY REGION, 2019–2032 (USD MILLION)
    51. –2032 (USD MILLION)
    52. MARKET, FOR PUSH TO TURN SYSTEM, BY REGION, 2019–2032 (USD MILLION)
    53. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR COLOR-TO-COLOR ALIGNMENT
    54. SYSTEM, BY REGION, 2019–2032 (USD MILLION)
    55. DRUG TRANSFER DEVICE MARKET, FOR LEUR LOCK SYSTEMS, BY REGION, 2019–2032 (USD
    56. MILLION)
    57. BY REGION, 2019–2032 (USD MILLION)
    58. TRANSFER DEVICE MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION)
    59. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR COMPARTMENTALIZE DEVICES,
    60. BY REGION, 2019–2032 (USD MILLION)
    61. TRANSFER DEVICE MARKET, FOR DIAPHRAGM-BASED DEVICES, BY REGION, 2019–2032
    62. (USD MILLION)
    63. AIR FILTRATION DEVICES, BY REGION, 2019–2032 (USD MILLION)
    64. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY END USER, 2019–2032 (USD MILLION)
    65. CLINICS, BY REGION, 2019–2032 (USD MILLION)
    66. DRUG TRANSFER DEVICE MARKET, FOR SPECIALTY CENTERS, BY REGION, 2019–2032 (USD
    67. MILLION)
    68. BY REGION, 2019–2032 (USD MILLION)
    69. TRANSFER DEVICES MARKET, BY REGION, 2019–2032 (USD MILLION)
    70. NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COUNTRY, 2019–2032
    71. (USD MILLION)
    72. BY TYPE, 2019–2032 (USD MILLION)
    73. DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019–2032 (USD MILLION)
    74. NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM,
    75. –2032 (USD MILLION)
    76. DEVICES MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION)
    77. AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019–2032
    78. (USD MILLION)
    79. –2032 (USD MILLION)
    80. MARKET, BY COMPONENT, 2019–2032 (USD MILLION)
    81. DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019–2032 (USD MILLION)
    82. (USD MILLION)
    83. USER, 2019–2032 (USD MILLION)
    84. DEVICES MARKET, BY TYPE, 2019–2032 (USD MILLION)
    85. SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019–2032 (USD MILLION)
    86. –2032 (USD MILLION)
    87. DEVICES MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION)
    88. CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019–2032 (USD MILLION)
    89. (USD MILLION)
    90. BY COMPONENT, 2019–2032 (USD MILLION)
    91. DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019–2032 (USD MILLION)
    92. (USD MILLION)
    93. BY END USER, 2019–2032 (USD MILLION)
    94. TRANSFER DEVICES MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
    95. EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019–2032 (USD
    96. MILLION)
    97. –2032 (USD MILLION)
    98. DEVICES MARKET, BY CLOSING MECHANISM, 2019–2032 (USD MILLION)
    99. EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2032
    100. (USD MILLION)
    101. BY END USER, 2019–2032 (USD MILLION)
    102. DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019–2032 (USD MILLION)
    103. GERMANY: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019–2032
    104. (USD MILLION)
    105. BY CLOSING MECHANISM, 2019–2032 (USD MILLION)
    106. SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION)
    107. (USD MILLION)
    108. BY TYPE, 2019–2032 (USD MILLION)
    109. TRANSFER DEVICES MARKET, BY COMPONENT, 2019–2032 (USD MILLION)
    110. FRANCE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019–2032
    111. (USD MILLION)
    112. BY TECHNOLOGY, 2019–2032 (USD MILLION)
    113. DRUG TRANSFER DEVICES MARKET, BY END USER, 2019–2032 (USD MILLION)
    114. UK: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019–2032 (USD
    115. MILLION)
    116. –2032 (USD MILLION)
    117. MARKET, BY CLOSING MECHANISM, 2019–2032 (USD MILLION)
    118. SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION)
    119. (USD MILLION)
    120. TYPE, 2019–2032 (USD MILLION)
    121. DEVICES MARKET, BY COMPONENT, 2019–2032 (USD MILLION)
    122. CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019–2032
    123. (USD MILLION)
    124. TECHNOLOGY, 2019–2032 (USD MILLION)
    125. TRANSFER DEVICES MARKET, BY END USER, 2019–2032 (USD MILLION)
    126. SPAIN: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019–2032 (USD
    127. MILLION)
    128. –2032 (USD MILLION)
    129. MARKET, BY CLOSING MECHANISM, 2019–2032 (USD MILLION)
    130. CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2032 (USD
    131. MILLION)
    132. USER, 2019–2032 (USD MILLION)
    133. DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019–2032 (USD MILLION)
    134. REST OF EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019–2032
    135. (USD MILLION)
    136. MARKET, BY CLOSING MECHANISM, 2019–2032 (USD MILLION)
    137. EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2032
    138. (USD MILLION)
    139. MARKET, BY END USER, 2019–2032 (USD MILLION)
    140. SYSTEM DRUG TRANSFER DEVICES MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
    141. (USD MILLION)
    142. BY COMPONENT, 2019–2032 (USD MILLION)
    143. DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019–2032 (USD MILLION)
    144. –2032 (USD MILLION)
    145. DEVICES MARKET, BY END USER, 2019–2032 (USD MILLION)
    146. CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019–2032 (USD MILLION)
    147. (USD MILLION)
    148. CLOSING MECHANISM, 2019–2032 (USD MILLION)
    149. DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION)
    150. CHINA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019–2032
    151. (USD MILLION)
    152. TYPE, 2019–2032 (USD MILLION)
    153. DEVICES MARKET, BY COMPONENT, 2019–2032 (USD MILLION)
    154. CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019–2032
    155. (USD MILLION)
    156. TECHNOLOGY, 2019–2032 (USD MILLION)
    157. TRANSFER DEVICES MARKET, BY END USER, 2019–2032 (USD MILLION)
    158. JAPAN: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019–2032 (USD
    159. MILLION)
    160. –2032 (USD MILLION)
    161. MARKET, BY CLOSING MECHANISM, 2019–2032 (USD MILLION)
    162. CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2032 (USD
    163. MILLION)
    164. USER, 2019–2032 (USD MILLION)
    165. TRANSFER DEVICES MARKET, BY TYPE, 2019–2032 (USD MILLION)
    166. KOREA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019–2032
    167. (USD MILLION)
    168. BY CLOSING MECHANISM, 2019–2032 (USD MILLION)
    169. CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2032 (USD
    170. MILLION)
    171. BY END USER, 2019–2032 (USD MILLION)
    172. DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019–2032 (USD MILLION)
    173. AUSTRALIA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019–2032
    174. (USD MILLION)
    175. BY CLOSING MECHANISM, 2019–2032 (USD MILLION)
    176. SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION)
    177. –2032 (USD MILLION)
    178. DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019–2032 (USD MILLION)
    179. REST OF ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT,
    180. –2032 (USD MILLION)
    181. DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019–2032 (USD MILLION)
    182. TECHNOLOGY, 2019–2032 (USD MILLION)
    183. SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019–2032 (USD MILLION)
    184. –2032 (USD MILLION)
    185. TRANSFER DEVICES MARKET, BY TYPE, 2019–2032 (USD MILLION)
    186. OF THE WORLD: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019–2032
    187. (USD MILLION)
    188. MARKET, BY CLOSING MECHANISM, 2019–2032 (USD MILLION)
    189. OF THE WORLD: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2032
    190. (USD MILLION)
    191. MARKET, BY END USER, 2019–2032 (USD MILLION)
    192. SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019–2032 (USD MILLION)
    193. MIDDLE EAST: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019–2032
    194. (USD MILLION)
    195. BY CLOSING MECHANISM, 2019–2032 (USD MILLION)
    196. CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2032 (USD
    197. MILLION)
    198. BY END USER, 2019–2032 (USD MILLION)
    199. DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019–2032 (USD MILLION)
    200. AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019–2032
    201. (USD MILLION)
    202. BY CLOSING MECHANISM, 2019–2032 (USD MILLION)
    203. SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION)
    204. (USD MILLION)
    205. MARKET, BY TYPE, 2019–2032 (USD MILLION)
    206. SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019–2032 (USD MILLION)
    207. MECHANISM, 2019–2032 (USD MILLION)
    208. DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION)
    209. LATIN AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019–2032
    210. (USD MILLION)
    211. OFFERED
    212. INC.: PRODUCTS OFFERED
    213. EQUASHIELD: PRODUCTS OFFERED
    214. PRODUCT OFFERED
    215. PRODUCTS OFFERED
    216. LTD: PRODUCT OFFERED
    217. SYSTEM DRUG TRANSFER DEVICE MARKET: STRUCTURE
    218. DRUG TRANSFER DEVICE MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
    219. DRIVER IMPACT ANALYSIS (2023-2032)
    220. DEVICE (CSTD) MARKET
    221. TYPE SEGMENT, (USD MILLION)
    222. MARKET, BY TYPE, 2023 & 2032 (USD MILLION)
    223. DRUG TRANSFER DEVICE MARKET SHARE (%), BY TYPE, 2023
    224. SYSTEM DRUG TRANSFER DEVICE MARKET; COMPONENT SEGMENT, (USD MILLION)
    225. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT, 2023 & 2032
    226. (USD MILLION)
    227. (%), BY COMPONENT, 2023
    228. MARKET; CLOSING MECHANISM SEGMENT, (USD MILLION)
    229. DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM, 2023 & 2032 (USD MILLION)
    230. MECHANISM, 2023
    231. TECHNOLOGY SEGMENT, (USD MILLION)
    232. DEVICE MARKET, BY TECHNOLOGY, 2023 & 2032 (USD MILLION)
    233. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET SHARE (%), BY TECHNOLOGY, 2023
    234. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET; END USER SEGMENT, (USD MILLION)
    235. & 2032 (USD MILLION)
    236. MARKET SHARE (%), BY END USER, 2023
    237. DEVICES MARKET, BY REGION, 2023 & 2032 (USD MILLION)
    238. SYSTEM DRUG TRANSFER DEVICES MARKET SHARE, BY REGION, 2023 (% SHARE)
    239. NORTH AMERICA MARKET ANALYSIS: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, 2019-2032
    240. (USD MILLION)
    241. SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
    242. SYSTEM DRUG TRANSFER DEVICES MARKET SHARE, BY COUNTRY, 2023 (%)
    243. MARKET ANALYSIS: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, 2019-2032 (USD MILLION)
    244. & 2032 (USD MILLION)
    245. DEVICES MARKET SHARE, BY COUNTRY, 2023 (%)
    246. CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, 2019-2032 (USD MILLION)
    247. ASIA-PACIFIC CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET SHARE, BY COUNTRY, 2023
    248. & 2032 (USD MILLION)
    249. DEVICES MARKET SHARE, BY COUNTRY, 2023 (%)
    250. ANALYSIS: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, 2019-2032 (USD MILLION)
    251. BY COUNTRY, 2023 & 2032 (USD MILLION)
    252. SYSTEM DRUG TRANSFER DEVICES MARKET SHARE, BY COUNTRY, 2023 (%)
    253. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET PLAYERS: COMPETITIVE ANALYSIS, 2023
    254. SWOT ANALYSIS
    255. ICU MEDICAL, INC.: FINANCIAL OVERVIEW SNAPSHOT
    256. SWOT ANALYSIS
    257. SWOT ANALYSIS
    258. BAXTER: SWOT ANALYSIS

    Closed System Drug Transfer Device Market Segmentation

    Global Closed System Drug Transfer Device Type Outlook (USD Billion, 2019-2032)

    • Membrane-To-Membrane Systems
    • Needleless Systems

    Global Closed System Drug Transfer Device Component Outlook (USD Billion, 2019-2032)

    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Global Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Global Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices

    Global Closed System Drug Transfer Device End-user Outlook (USD Billion, 2019-2032)

    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Global Closed System Drug Transfer Device Regional Outlook (USD Billion, 2019-2032

    North America Outlook (USD Billion, 2019-2032)

    North America Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    North America Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    North America Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    North America Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    North America Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    US Outlook (USD Billion, 2019-2032)

    US Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    US Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    US Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    US Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    US Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Canada Outlook (USD Billion, 2019-2032)

    Canada Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Canada Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Canada Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Canada Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Canada Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Mexico Outlook (USD Billion, 2019-2032)

    Mexico Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Mexico Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

     

     

    Mexico Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Mexico Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Mexico Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Europe Outlook (USD Billion, 2019-2032)

    Europe Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Europe Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Europe Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Europe Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Europe Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Germany Outlook (USD Billion, 2019-2032)

    Germany Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Germany Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Germany Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

     

     

    Germany Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Germany Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    France Outlook (USD Billion, 2019-2032)

    France Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    France Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    France Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    France Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    France Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    UK Outlook (USD Billion, 2019-2032)

    UK Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    UK Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    UK Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    UK Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    UK Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Italy Outlook (USD Billion, 2019-2032)

    Italy Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Italy Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Italy Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Italy Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Italy Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Contract Research Organizations (CROs)

    Spain Outlook (USD Billion, 2019-2032)

    Spain Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Spain Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Spain Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Spain Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Spain Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Rest Of Europe Outlook (USD Billion, 2019-2032)

    Rest of Europe Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Rest of Europe Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Rest of Europe Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Rest of Europe Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Rest of Europe Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Asia-Pacific Outlook (USD Billion, 2019-2032)

    Asia-Pacific Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Asia-Pacific Global Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Asia-Pacific Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Asia-Pacific Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Asia-Pacific Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    China Outlook (USD Billion, 2019-2032)

    China Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    China Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    China Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    China Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    China Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Japan Outlook (USD Billion, 2019-2032)

    Japan Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Japan Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Japan Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

     

     

    Japan Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Japan Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    India Outlook (USD Billion, 2019-2032)

    India Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    India Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    India Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    India Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    India Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Australia Outlook (USD Billion, 2019-2032)

    Australia Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Australia Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Australia Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Australia Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Australia Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Rest of Asia-Pacific Outlook (USD Billion, 2019-2032)

    Rest of Asia-Pacific Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Rest of Asia-Pacific Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Rest of Asia-Pacific Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Rest of Asia-Pacific Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Rest of Asia-Pacific Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Rest of the World Outlook (USD Billion, 2019-2032)

    Rest of World Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Rest of the World Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Rest of the World Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Rest of the World Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Rest of World Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Middle East & Africa Outlook (USD Billion, 2019-2032)

    Middle East & Africa Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems

     

     

    Middle East & Africa Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Middle East & Africa Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Middle East & Africa Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Middle East & Africa Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    South America Outlook (USD Billion, 2019-2032)

    South America Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    South America Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    South America Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    South America Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    South America Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others
    Closed System Drug Transfer Device Market Research Report - Forecast till 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027